CGTX - CIK 0001455365
The table below shows COGNITION THERAPEUTICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $37.19M | $41.68M | $37.20M | $30.32M | $18.57M | $12.89M |
| SG&A | $10.61M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $12.29M |
| $13.53M |
| $13.23M |
| $10.03M |
| $4.52M |
| Operating income | -$47.80M | -$53.97M | -$50.72M | -$43.55M | -$28.60M | -$17.41M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | - |
| Net income | -$23.49M | -$33.97M | -$25.79M | -$21.40M | -$11.72M | -$7.84M |
| EPS (diluted) | -$0.32 | -$0.86 | -$0.86 | -$0.91 | -$3.13 | -$23.76 |